Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Inv. presentation

Greenwich LifeSciences, Inc. (GLSI) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/12/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/05/2023 4 Patel Snehal (CEO and CFO) has filed a Form 4 on Greenwich LifeSciences, Inc.
Txns: Bought 2,000 shares @ $8.63, valued at $17.3k
09/28/2023 4 Thompson Jaye (VP Clinical Reg Affairs) has filed a Form 4 on Greenwich LifeSciences, Inc.
Txns: Bought 600 shares @ $8.71, valued at $5.2k
08/24/2023 4 Patel Snehal (CEO and CFO) has filed a Form 4 on Greenwich LifeSciences, Inc.
Txns: Bought 1,000 shares @ $9.97, valued at $10k
08/21/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/14/2023 NT 10-Q Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
08/08/2023 4 Patel Snehal (CEO and CFO) has filed a Form 4 on Greenwich LifeSciences, Inc.
Txns: Bought 2,000 shares @ $10.55, valued at $21.1k
07/25/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/17/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/18/2023 4 Patel Snehal (CEO and CFO) has filed a Form 4 on Greenwich LifeSciences, Inc.
Txns: Bought 1,000 shares @ $11.69, valued at $11.7k
05/02/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/21/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/20/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/31/2023 10-K Annual Report for the period ended December 31, 2022
03/16/2023 4 Thompson Jaye (VP Clinical Reg Affairs) has filed a Form 4 on Greenwich LifeSciences, Inc.
Txns: Bought 250 shares @ $12.71, valued at $3.2k
03/13/2023 4 Patel Snehal (CEO and CFO) has filed a Form 4 on Greenwich LifeSciences, Inc.
Txns: Bought 1,000 shares @ $12.12, valued at $12.1k
03/13/2023 8-K Other Events  Interactive Data
02/28/2023 4 Thompson Jaye (VP Clinical Reg Affairs) has filed a Form 4 on Greenwich LifeSciences, Inc.
Txns: Bought 250 shares @ $15.395, valued at $3.8k
02/22/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/14/2023 4 Patel Snehal (CEO and CFO) has filed a Form 4 on Greenwich LifeSciences, Inc.
Txns: Bought 1,000 shares @ $18.68, valued at $18.7k
02/07/2023 4 Thompson Jaye (VP Clinical Reg Affairs) has filed a Form 4 on Greenwich LifeSciences, Inc.
Txns: Bought 250 shares @ $20.84, valued at $5.2k
01/31/2023 4 Patel Snehal (CEO and CFO) has filed a Form 4 on Greenwich LifeSciences, Inc.
Txns: Bought 2,000 shares @ $19.35, valued at $38.7k
01/30/2023 4 Thompson Jaye (VP Clinical Reg Affairs) has filed a Form 4 on Greenwich LifeSciences, Inc.
Txns: Bought 250 shares @ $19.2, valued at $4.8k
01/24/2023 4 Patel Snehal (CEO and CFO) has filed a Form 4 on Greenwich LifeSciences, Inc.
Txns: Bought 1,500 shares @ $17.37, valued at $26.1k
01/17/2023 4 Thompson Jaye (VP Clinical Reg Affairs) has filed a Form 4 on Greenwich LifeSciences, Inc.
Txns: Bought 250 shares @ $16.5, valued at $4.1k
01/10/2023 4 Patel Snehal (CEO and CFO) has filed a Form 4 on Greenwich LifeSciences, Inc.
Txns: Bought 1,500 shares @ $15.18, valued at $22.8k
01/03/2023 4 Patel Snehal (CEO and CFO) has filed a Form 4 on Greenwich LifeSciences, Inc.
Txns: Bought 4,000 shares @ $15.19, valued at $60.8k
12/20/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/20/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/13/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/09/2022 8-K Quarterly results
12/06/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/06/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/14/2022 10-Q Quarterly Report for the period ended September 30, 2022
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy